Medtronic puts RF (radiofrequency) "pen" in US trial for atrial fibrillation
This article was originally published in Clinica
Executive Summary
In a bid to expand the US market for its radiofrequency (RF) ablation "pen", Cardioblate, Medtronic has begun a clinical study of the device as a treatment for atrial fibrillation (AF).